Copyright
©The Author(s) 2016.
World J Gastroenterol. Feb 14, 2016; 22(6): 2071-2080
Published online Feb 14, 2016. doi: 10.3748/wjg.v22.i6.2071
Published online Feb 14, 2016. doi: 10.3748/wjg.v22.i6.2071
Figure 4 NICD/shP53/IDH1R132C induced ICC formation in mice.
A: Gross images of NICD/shP53/IDH1R132C injected mice harvested at 12 wk post injection (a) and 18 wk post injection (b). The arrow indicates a cystic lesion on the liver surface; B: Hematoxylin-eosin stained images of the corresponding liver sections showing liver tumors from NICD/shP53/IDH1R132C injected mice.
- Citation: Ding N, Che L, Li XL, Liu Y, Jiang LJ, Fan B, Tao JY, Chen X, Ji JF. Oncogenic potential of IDH1R132C mutant in cholangiocarcinoma development in mice. World J Gastroenterol 2016; 22(6): 2071-2080
- URL: https://www.wjgnet.com/1007-9327/full/v22/i6/2071.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i6.2071